IBDEI00M ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,935,0)
 ;;=C22.0^^10^71^4
 ;;^UTILITY(U,$J,358.3,935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,935,1,3,0)
 ;;=3^Liver cell carcinoma
 ;;^UTILITY(U,$J,358.3,935,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,935,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,936,0)
 ;;=C22.4^^10^71^19
 ;;^UTILITY(U,$J,358.3,936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,936,1,3,0)
 ;;=3^Sarcomas of Liver NEC
 ;;^UTILITY(U,$J,358.3,936,1,4,0)
 ;;=4^C22.4
 ;;^UTILITY(U,$J,358.3,936,2)
 ;;=^5000937
 ;;^UTILITY(U,$J,358.3,937,0)
 ;;=C22.3^^10^71^1
 ;;^UTILITY(U,$J,358.3,937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,937,1,3,0)
 ;;=3^Angiosarcoma of liver
 ;;^UTILITY(U,$J,358.3,937,1,4,0)
 ;;=4^C22.3
 ;;^UTILITY(U,$J,358.3,937,2)
 ;;=^5000936
 ;;^UTILITY(U,$J,358.3,938,0)
 ;;=C23.^^10^71^11
 ;;^UTILITY(U,$J,358.3,938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,938,1,3,0)
 ;;=3^Malignant neoplasm of gallbladder
 ;;^UTILITY(U,$J,358.3,938,1,4,0)
 ;;=4^C23.
 ;;^UTILITY(U,$J,358.3,938,2)
 ;;=^267098
 ;;^UTILITY(U,$J,358.3,939,0)
 ;;=C24.0^^10^71^10
 ;;^UTILITY(U,$J,358.3,939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,939,1,3,0)
 ;;=3^Malignant neoplasm of extrahepatic bile duct
 ;;^UTILITY(U,$J,358.3,939,1,4,0)
 ;;=4^C24.0
 ;;^UTILITY(U,$J,358.3,939,2)
 ;;=^5000940
 ;;^UTILITY(U,$J,358.3,940,0)
 ;;=C24.1^^10^71^5
 ;;^UTILITY(U,$J,358.3,940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,940,1,3,0)
 ;;=3^Malignant neoplasm of ampulla of Vater
 ;;^UTILITY(U,$J,358.3,940,1,4,0)
 ;;=4^C24.1
 ;;^UTILITY(U,$J,358.3,940,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,941,0)
 ;;=C25.9^^10^71^14
 ;;^UTILITY(U,$J,358.3,941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,941,1,3,0)
 ;;=3^Malignant neoplasm of pancreas, unspecified
 ;;^UTILITY(U,$J,358.3,941,1,4,0)
 ;;=4^C25.9
 ;;^UTILITY(U,$J,358.3,941,2)
 ;;=^5000946
 ;;^UTILITY(U,$J,358.3,942,0)
 ;;=C19.^^10^71^15
 ;;^UTILITY(U,$J,358.3,942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,942,1,3,0)
 ;;=3^Malignant neoplasm of rectosigmoid junction
 ;;^UTILITY(U,$J,358.3,942,1,4,0)
 ;;=4^C19.
 ;;^UTILITY(U,$J,358.3,942,2)
 ;;=^267089
 ;;^UTILITY(U,$J,358.3,943,0)
 ;;=C24.8^^10^71^13
 ;;^UTILITY(U,$J,358.3,943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,943,1,3,0)
 ;;=3^Malignant neoplasm of overlapping sites of biliary tract
 ;;^UTILITY(U,$J,358.3,943,1,4,0)
 ;;=4^C24.8
 ;;^UTILITY(U,$J,358.3,943,2)
 ;;=^5000941
 ;;^UTILITY(U,$J,358.3,944,0)
 ;;=C24.9^^10^71^7
 ;;^UTILITY(U,$J,358.3,944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,944,1,3,0)
 ;;=3^Malignant neoplasm of biliary tract,unspec
 ;;^UTILITY(U,$J,358.3,944,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,944,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,945,0)
 ;;=C01.^^10^72^2
 ;;^UTILITY(U,$J,358.3,945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,945,1,3,0)
 ;;=3^Malignant neoplasm of base of tongue
 ;;^UTILITY(U,$J,358.3,945,1,4,0)
 ;;=4^C01.
 ;;^UTILITY(U,$J,358.3,945,2)
 ;;=^266996
 ;;^UTILITY(U,$J,358.3,946,0)
 ;;=C02.9^^10^72^17
 ;;^UTILITY(U,$J,358.3,946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,946,1,3,0)
 ;;=3^Malignant neoplasm of tongue, unspecified
 ;;^UTILITY(U,$J,358.3,946,1,4,0)
 ;;=4^C02.9
 ;;^UTILITY(U,$J,358.3,946,2)
 ;;=^5000891
 ;;^UTILITY(U,$J,358.3,947,0)
 ;;=C04.9^^10^72^3
 ;;^UTILITY(U,$J,358.3,947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,947,1,3,0)
 ;;=3^Malignant neoplasm of floor of mouth, unspecified
 ;;^UTILITY(U,$J,358.3,947,1,4,0)
 ;;=4^C04.9
 ;;^UTILITY(U,$J,358.3,947,2)
 ;;=^5000896
 ;;^UTILITY(U,$J,358.3,948,0)
 ;;=C06.9^^10^72^8
 ;;^UTILITY(U,$J,358.3,948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,948,1,3,0)
 ;;=3^Malignant neoplasm of mouth, unspecified
 ;;^UTILITY(U,$J,358.3,948,1,4,0)
 ;;=4^C06.9
 ;;^UTILITY(U,$J,358.3,948,2)
 ;;=^5000901
 ;;^UTILITY(U,$J,358.3,949,0)
 ;;=C10.9^^10^72^10
 ;;^UTILITY(U,$J,358.3,949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,949,1,3,0)
 ;;=3^Malignant neoplasm of oropharynx, unspecified
 ;;^UTILITY(U,$J,358.3,949,1,4,0)
 ;;=4^C10.9
 ;;^UTILITY(U,$J,358.3,949,2)
 ;;=^5000909
 ;;^UTILITY(U,$J,358.3,950,0)
 ;;=C11.9^^10^72^9
 ;;^UTILITY(U,$J,358.3,950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,950,1,3,0)
 ;;=3^Malignant neoplasm of nasopharynx, unspecified
 ;;^UTILITY(U,$J,358.3,950,1,4,0)
 ;;=4^C11.9
 ;;^UTILITY(U,$J,358.3,950,2)
 ;;=^5000911
 ;;^UTILITY(U,$J,358.3,951,0)
 ;;=C31.9^^10^72^1
 ;;^UTILITY(U,$J,358.3,951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,951,1,3,0)
 ;;=3^Malignant neoplasm of accessory sinus, unspecified
 ;;^UTILITY(U,$J,358.3,951,1,4,0)
 ;;=4^C31.9
 ;;^UTILITY(U,$J,358.3,951,2)
 ;;=^5000953
 ;;^UTILITY(U,$J,358.3,952,0)
 ;;=C32.9^^10^72^6
 ;;^UTILITY(U,$J,358.3,952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,952,1,3,0)
 ;;=3^Malignant neoplasm of larynx, unspecified
 ;;^UTILITY(U,$J,358.3,952,1,4,0)
 ;;=4^C32.9
 ;;^UTILITY(U,$J,358.3,952,2)
 ;;=^5000956
 ;;^UTILITY(U,$J,358.3,953,0)
 ;;=C33.^^10^72^19
 ;;^UTILITY(U,$J,358.3,953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,953,1,3,0)
 ;;=3^Malignant neoplasm of trachea
 ;;^UTILITY(U,$J,358.3,953,1,4,0)
 ;;=4^C33.
 ;;^UTILITY(U,$J,358.3,953,2)
 ;;=^267135
 ;;^UTILITY(U,$J,358.3,954,0)
 ;;=C34.91^^10^72^21
 ;;^UTILITY(U,$J,358.3,954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,954,1,3,0)
 ;;=3^Malignant neoplasm of unsp part of right bronchus or lung
 ;;^UTILITY(U,$J,358.3,954,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,954,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,955,0)
 ;;=C34.92^^10^72^20
 ;;^UTILITY(U,$J,358.3,955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,955,1,3,0)
 ;;=3^Malignant neoplasm of unsp part of left bronchus or lung
 ;;^UTILITY(U,$J,358.3,955,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,955,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,956,0)
 ;;=C38.4^^10^72^14
 ;;^UTILITY(U,$J,358.3,956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,956,1,3,0)
 ;;=3^Malignant neoplasm of pleura
 ;;^UTILITY(U,$J,358.3,956,1,4,0)
 ;;=4^C38.4
 ;;^UTILITY(U,$J,358.3,956,2)
 ;;=^267140
 ;;^UTILITY(U,$J,358.3,957,0)
 ;;=C45.0^^10^72^22
 ;;^UTILITY(U,$J,358.3,957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,957,1,3,0)
 ;;=3^Mesothelioma of pleura
 ;;^UTILITY(U,$J,358.3,957,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,957,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,958,0)
 ;;=C73.^^10^72^16
 ;;^UTILITY(U,$J,358.3,958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,958,1,3,0)
 ;;=3^Malignant neoplasm of thyroid gland
 ;;^UTILITY(U,$J,358.3,958,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,958,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,959,0)
 ;;=C76.0^^10^72^4
 ;;^UTILITY(U,$J,358.3,959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,959,1,3,0)
 ;;=3^Malignant neoplasm of head, face and neck
 ;;^UTILITY(U,$J,358.3,959,1,4,0)
 ;;=4^C76.0
 ;;^UTILITY(U,$J,358.3,959,2)
 ;;=^5001324
 ;;^UTILITY(U,$J,358.3,960,0)
 ;;=C05.9^^10^72^11
 ;;^UTILITY(U,$J,358.3,960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,960,1,3,0)
 ;;=3^Malignant neoplasm of palate,unspec
 ;;^UTILITY(U,$J,358.3,960,1,4,0)
 ;;=4^C05.9
 ;;^UTILITY(U,$J,358.3,960,2)
 ;;=^5000898
 ;;^UTILITY(U,$J,358.3,961,0)
 ;;=C07.^^10^72^12
 ;;^UTILITY(U,$J,358.3,961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,961,1,3,0)
 ;;=3^Malignant neoplasm of parotid gland
 ;;^UTILITY(U,$J,358.3,961,1,4,0)
 ;;=4^C07.
 ;;^UTILITY(U,$J,358.3,961,2)
 ;;=^267005
 ;;^UTILITY(U,$J,358.3,962,0)
 ;;=C08.9^^10^72^7
 ;;^UTILITY(U,$J,358.3,962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,962,1,3,0)
 ;;=3^Malignant neoplasm of major salivary gland,unspec
 ;;^UTILITY(U,$J,358.3,962,1,4,0)
 ;;=4^C08.9
 ;;^UTILITY(U,$J,358.3,962,2)
 ;;=^5000902
 ;;^UTILITY(U,$J,358.3,963,0)
 ;;=C09.9^^10^72^18
 ;;^UTILITY(U,$J,358.3,963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,963,1,3,0)
 ;;=3^Malignant neoplasm of tonsil,unspec
 ;;^UTILITY(U,$J,358.3,963,1,4,0)
 ;;=4^C09.9
 ;;^UTILITY(U,$J,358.3,963,2)
 ;;=^5000905
 ;;^UTILITY(U,$J,358.3,964,0)
 ;;=C12.^^10^72^15
 ;;^UTILITY(U,$J,358.3,964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,964,1,3,0)
 ;;=3^Malignant neoplasm of pyriform sinus
 ;;^UTILITY(U,$J,358.3,964,1,4,0)
 ;;=4^C12.
 ;;^UTILITY(U,$J,358.3,964,2)
 ;;=^267046
 ;;^UTILITY(U,$J,358.3,965,0)
 ;;=C13.9^^10^72^5
 ;;^UTILITY(U,$J,358.3,965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,965,1,3,0)
 ;;=3^Malignant neoplasm of hypopharynx,unspec
 ;;^UTILITY(U,$J,358.3,965,1,4,0)
 ;;=4^C13.9
 ;;^UTILITY(U,$J,358.3,965,2)
 ;;=^5000915
 ;;^UTILITY(U,$J,358.3,966,0)
 ;;=C14.0^^10^72^13
 ;;^UTILITY(U,$J,358.3,966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,966,1,3,0)
 ;;=3^Malignant neoplasm of pharynx,unspec
 ;;^UTILITY(U,$J,358.3,966,1,4,0)
 ;;=4^C14.0
 ;;^UTILITY(U,$J,358.3,966,2)
 ;;=^5000916
 ;;^UTILITY(U,$J,358.3,967,0)
 ;;=D57.40^^10^73^15
 ;;^UTILITY(U,$J,358.3,967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,967,1,3,0)
 ;;=3^Sickle-cell thalassemia without crisis
 ;;^UTILITY(U,$J,358.3,967,1,4,0)
 ;;=4^D57.40
 ;;^UTILITY(U,$J,358.3,967,2)
 ;;=^329908
 ;;^UTILITY(U,$J,358.3,968,0)
 ;;=D57.419^^10^73^14
 ;;^UTILITY(U,$J,358.3,968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,968,1,3,0)
 ;;=3^Sickle-cell thalassemia with crisis, unspecified
 ;;^UTILITY(U,$J,358.3,968,1,4,0)
 ;;=4^D57.419
 ;;^UTILITY(U,$J,358.3,968,2)
 ;;=^5002316
 ;;^UTILITY(U,$J,358.3,969,0)
 ;;=D56.0^^10^73^1
 ;;^UTILITY(U,$J,358.3,969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,969,1,3,0)
 ;;=3^Alpha thalassemia
 ;;^UTILITY(U,$J,358.3,969,1,4,0)
 ;;=4^D56.0
 ;;^UTILITY(U,$J,358.3,969,2)
 ;;=^340494
 ;;^UTILITY(U,$J,358.3,970,0)
 ;;=D56.1^^10^73^2
 ;;^UTILITY(U,$J,358.3,970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,970,1,3,0)
 ;;=3^Beta thalassemia
 ;;^UTILITY(U,$J,358.3,970,1,4,0)
 ;;=4^D56.1
 ;;^UTILITY(U,$J,358.3,970,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,971,0)
 ;;=D56.2^^10^73^3
 ;;^UTILITY(U,$J,358.3,971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,971,1,3,0)
 ;;=3^Delta-beta thalassemia
 ;;^UTILITY(U,$J,358.3,971,1,4,0)
 ;;=4^D56.2
 ;;^UTILITY(U,$J,358.3,971,2)
 ;;=^340496
 ;;^UTILITY(U,$J,358.3,972,0)
 ;;=D56.3^^10^73^18
 ;;^UTILITY(U,$J,358.3,972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,972,1,3,0)
 ;;=3^Thalassemia minor
 ;;^UTILITY(U,$J,358.3,972,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,972,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,973,0)
 ;;=D56.5^^10^73^7
 ;;^UTILITY(U,$J,358.3,973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,973,1,3,0)
 ;;=3^Hemoglobin E-beta thalassemia
 ;;^UTILITY(U,$J,358.3,973,1,4,0)
 ;;=4^D56.5
 ;;^UTILITY(U,$J,358.3,973,2)
 ;;=^340498
 ;;^UTILITY(U,$J,358.3,974,0)
 ;;=D56.8^^10^73^19
 ;;^UTILITY(U,$J,358.3,974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,974,1,3,0)
 ;;=3^Thalassemias NEC
 ;;^UTILITY(U,$J,358.3,974,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,974,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,975,0)
 ;;=D57.3^^10^73^16
 ;;^UTILITY(U,$J,358.3,975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,975,1,3,0)
 ;;=3^Sickle-cell trait
 ;;^UTILITY(U,$J,358.3,975,1,4,0)
 ;;=4^D57.3
 ;;^UTILITY(U,$J,358.3,975,2)
 ;;=^5002313
 ;;^UTILITY(U,$J,358.3,976,0)
 ;;=D57.1^^10^73^13
 ;;^UTILITY(U,$J,358.3,976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,976,1,3,0)
 ;;=3^Sickle-cell disease without crisis
 ;;^UTILITY(U,$J,358.3,976,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,976,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,977,0)
 ;;=D57.02^^10^73^6
 ;;^UTILITY(U,$J,358.3,977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,977,1,3,0)
 ;;=3^Hb-SS disease with splenic sequestration
 ;;^UTILITY(U,$J,358.3,977,1,4,0)
 ;;=4^D57.02
 ;;^UTILITY(U,$J,358.3,977,2)
 ;;=^5002308
 ;;^UTILITY(U,$J,358.3,978,0)
 ;;=D57.01^^10^73^4
 ;;^UTILITY(U,$J,358.3,978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,978,1,3,0)
 ;;=3^Hb-SS disease with acute chest syndrome
 ;;^UTILITY(U,$J,358.3,978,1,4,0)
 ;;=4^D57.01
 ;;^UTILITY(U,$J,358.3,978,2)
 ;;=^5002307
 ;;^UTILITY(U,$J,358.3,979,0)
 ;;=D57.00^^10^73^5
 ;;^UTILITY(U,$J,358.3,979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,979,1,3,0)
 ;;=3^Hb-SS disease with crisis, unspecified
 ;;^UTILITY(U,$J,358.3,979,1,4,0)
 ;;=4^D57.00
 ;;^UTILITY(U,$J,358.3,979,2)
 ;;=^5002306
 ;;^UTILITY(U,$J,358.3,980,0)
 ;;=D57.20^^10^73^17
 ;;^UTILITY(U,$J,358.3,980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,980,1,3,0)
 ;;=3^Sickle-cell/Hb-C disease without crisis
 ;;^UTILITY(U,$J,358.3,980,1,4,0)
 ;;=4^D57.20
 ;;^UTILITY(U,$J,358.3,980,2)
 ;;=^330080
 ;;^UTILITY(U,$J,358.3,981,0)
 ;;=D57.811^^10^73^10
 ;;^UTILITY(U,$J,358.3,981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,981,1,3,0)
 ;;=3^Sickle-Cell Disorders w/ Acute Chest Syndrome NEC
 ;;^UTILITY(U,$J,358.3,981,1,4,0)
 ;;=4^D57.811
 ;;^UTILITY(U,$J,358.3,981,2)
 ;;=^5002318
 ;;^UTILITY(U,$J,358.3,982,0)
 ;;=D57.812^^10^73^11
 ;;^UTILITY(U,$J,358.3,982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,982,1,3,0)
 ;;=3^Sickle-Cell Disorders w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,982,1,4,0)
 ;;=4^D57.812
 ;;^UTILITY(U,$J,358.3,982,2)
 ;;=^5002319
 ;;^UTILITY(U,$J,358.3,983,0)
 ;;=D57.819^^10^73^12
 ;;^UTILITY(U,$J,358.3,983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,983,1,3,0)
 ;;=3^Sickle-Cell Disorders w/ Unspec Crisis NEC
 ;;^UTILITY(U,$J,358.3,983,1,4,0)
 ;;=4^D57.819
 ;;^UTILITY(U,$J,358.3,983,2)
 ;;=^5002320
 ;;^UTILITY(U,$J,358.3,984,0)
 ;;=D58.8^^10^73^9
 ;;^UTILITY(U,$J,358.3,984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,984,1,3,0)
 ;;=3^Hereditary Hemolytic Anemias NEC
 ;;^UTILITY(U,$J,358.3,984,1,4,0)
 ;;=4^D58.8
 ;;^UTILITY(U,$J,358.3,984,2)
 ;;=^267984
 ;;^UTILITY(U,$J,358.3,985,0)
 ;;=D58.2^^10^73^8
 ;;^UTILITY(U,$J,358.3,985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,985,1,3,0)
 ;;=3^Hemoglobinopathies NEC
 ;;^UTILITY(U,$J,358.3,985,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,985,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,986,0)
 ;;=C83.10^^10^74^52
 ;;^UTILITY(U,$J,358.3,986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,986,1,3,0)
 ;;=3^Mantle cell lymphoma, unspecified site
 ;;^UTILITY(U,$J,358.3,986,1,4,0)
 ;;=4^C83.10
 ;;^UTILITY(U,$J,358.3,986,2)
 ;;=^5001561
 ;;^UTILITY(U,$J,358.3,987,0)
 ;;=C83.19^^10^74^51
 ;;^UTILITY(U,$J,358.3,987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,987,1,3,0)
 ;;=3^Mantle cell lymphoma, extranodal and solid organ sites
 ;;^UTILITY(U,$J,358.3,987,1,4,0)
 ;;=4^C83.19
 ;;^UTILITY(U,$J,358.3,987,2)
 ;;=^5001570
 ;;^UTILITY(U,$J,358.3,988,0)
 ;;=C83.50^^10^74^45
 ;;^UTILITY(U,$J,358.3,988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,988,1,3,0)
 ;;=3^Lymphoblastic (diffuse) lymphoma, unspecified site
 ;;^UTILITY(U,$J,358.3,988,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,988,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,989,0)
 ;;=C83.59^^10^74^46
 ;;^UTILITY(U,$J,358.3,989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,989,1,3,0)
 ;;=3^Lymphoblastic lymphoma, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,989,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,989,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,990,0)
 ;;=C83.70^^10^74^12
 ;;^UTILITY(U,$J,358.3,990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,990,1,3,0)
 ;;=3^Burkitt lymphoma, unspecified site
 ;;^UTILITY(U,$J,358.3,990,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,990,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,991,0)
 ;;=C83.79^^10^74^11
 ;;^UTILITY(U,$J,358.3,991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,991,1,3,0)
 ;;=3^Burkitt lymphoma, extranodal and solid organ sites
 ;;^UTILITY(U,$J,358.3,991,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,991,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,992,0)
 ;;=C81.00^^10^74^61
 ;;^UTILITY(U,$J,358.3,992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,992,1,3,0)
 ;;=3^Nodular lymphocyte predominant Hodgkin lymphoma, unsp site
 ;;^UTILITY(U,$J,358.3,992,1,4,0)
 ;;=4^C81.00
 ;;^UTILITY(U,$J,358.3,992,2)
 ;;=^5001391
 ;;^UTILITY(U,$J,358.3,993,0)
 ;;=C83.39^^10^74^22
 ;;^UTILITY(U,$J,358.3,993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,993,1,3,0)
 ;;=3^Diffuse large B-cell lymphoma, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,993,1,4,0)
 ;;=4^C83.39
 ;;^UTILITY(U,$J,358.3,993,2)
 ;;=^5001580
 ;;^UTILITY(U,$J,358.3,994,0)
 ;;=C81.09^^10^74^62
 ;;^UTILITY(U,$J,358.3,994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,994,1,3,0)
 ;;=3^Nodular lymphocyte predominant Hodgkin lymphoma, extrnod & solid org site
 ;;^UTILITY(U,$J,358.3,994,1,4,0)
 ;;=4^C81.09
 ;;^UTILITY(U,$J,358.3,994,2)
 ;;=^5001400
 ;;^UTILITY(U,$J,358.3,995,0)
 ;;=C81.10^^10^74^63
 ;;^UTILITY(U,$J,358.3,995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,995,1,3,0)
 ;;=3^Nodular sclerosis classical Hodgkin lymphoma, unsp site
 ;;^UTILITY(U,$J,358.3,995,1,4,0)
 ;;=4^C81.10
 ;;^UTILITY(U,$J,358.3,995,2)
 ;;=^5001401
 ;;^UTILITY(U,$J,358.3,996,0)
 ;;=C81.19^^10^74^64
 ;;^UTILITY(U,$J,358.3,996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,996,1,3,0)
 ;;=3^Nodular sclerosis classical Hodgkin lymphoma,extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,996,1,4,0)
 ;;=4^C81.19
 ;;^UTILITY(U,$J,358.3,996,2)
 ;;=^5001410
 ;;^UTILITY(U,$J,358.3,997,0)
 ;;=C81.20^^10^74^54
 ;;^UTILITY(U,$J,358.3,997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,997,1,3,0)
 ;;=3^Mixed cellularity classical Hodgkin lymphoma, unsp site
 ;;^UTILITY(U,$J,358.3,997,1,4,0)
 ;;=4^C81.20
 ;;^UTILITY(U,$J,358.3,997,2)
 ;;=^5001411
 ;;^UTILITY(U,$J,358.3,998,0)
 ;;=C81.29^^10^74^53
 ;;^UTILITY(U,$J,358.3,998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,998,1,3,0)
 ;;=3^Mix cellular class Hdgkn lymph, extrnod and solid org sites
 ;;^UTILITY(U,$J,358.3,998,1,4,0)
 ;;=4^C81.29
 ;;^UTILITY(U,$J,358.3,998,2)
 ;;=^5001420
 ;;^UTILITY(U,$J,358.3,999,0)
 ;;=C81.30^^10^74^48
 ;;^UTILITY(U,$J,358.3,999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,999,1,3,0)
 ;;=3^Lymphocyte depleted classical Hodgkin lymphoma, unsp site
 ;;^UTILITY(U,$J,358.3,999,1,4,0)
 ;;=4^C81.30
 ;;^UTILITY(U,$J,358.3,999,2)
 ;;=^5001421
 ;;^UTILITY(U,$J,358.3,1000,0)
 ;;=C81.39^^10^74^47
 ;;^UTILITY(U,$J,358.3,1000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1000,1,3,0)
 ;;=3^Lymphocy deplet class Hdgkn lymph, extrnod & solid org site
 ;;^UTILITY(U,$J,358.3,1000,1,4,0)
 ;;=4^C81.39
 ;;^UTILITY(U,$J,358.3,1000,2)
 ;;=^5001430
 ;;^UTILITY(U,$J,358.3,1001,0)
 ;;=C81.40^^10^74^49
 ;;^UTILITY(U,$J,358.3,1001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1001,1,3,0)
 ;;=3^Lymphocyte-rich classical Hodgkin lymphoma, unspecified site
 ;;^UTILITY(U,$J,358.3,1001,1,4,0)
 ;;=4^C81.40
 ;;^UTILITY(U,$J,358.3,1001,2)
 ;;=^5001431
 ;;^UTILITY(U,$J,358.3,1002,0)
 ;;=C81.49^^10^74^44
 ;;^UTILITY(U,$J,358.3,1002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1002,1,3,0)
 ;;=3^Lymp-rich class Hodgkin lymph, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,1002,1,4,0)
 ;;=4^C81.49
 ;;^UTILITY(U,$J,358.3,1002,2)
 ;;=^5001440
 ;;^UTILITY(U,$J,358.3,1003,0)
 ;;=C81.99^^10^74^42
 ;;^UTILITY(U,$J,358.3,1003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1003,1,3,0)
 ;;=3^Hodgkin lymphoma, unsp, extranodal and solid organ sites
 ;;^UTILITY(U,$J,358.3,1003,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,1003,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,1004,0)
 ;;=C81.90^^10^74^43
